...
首页> 外文期刊>Molecular pharmaceutics >Versatile Polymeric Microspheres with Tumor Microenvironment Bioreducible Degradation, pH-Activated Surface Charge Reversal, pH-Triggered 'off-on' Fluorescence and Drug Release as Theranostic Nanoplatforms
【24h】

Versatile Polymeric Microspheres with Tumor Microenvironment Bioreducible Degradation, pH-Activated Surface Charge Reversal, pH-Triggered 'off-on' Fluorescence and Drug Release as Theranostic Nanoplatforms

机译:多功能聚合物微球,具有肿瘤微环境生物的可遗产降解,pH-活化表面电荷反转,pH-触发“脱机”荧光和药物释放为Theranostic Nanoplatforms

获取原文
获取原文并翻译 | 示例

摘要

Facile approach has been developed for the versatile polymeric microspheres with tumor-microenvironment bioreducible degradation, pH-activated surface charge-reversal, pH-triggered "off-on" fluorescence and drug release via emulsion copolymerization of glycidyl methacrylate (GMA), poly(ethylene glycol) methyl ether methacrylate (PEGMA), N-rhodamine 6G-ethyl-acrylamide (Rh6GEAm) with N,N-bis(acyloyl)cystamine) (BACy) as disulfide crosslinker and functionalization. The final PGMA-DMMA microspheres showed excellent cytocompatibility, pH-triggered surface charge reversal at pH 5-6, strong fluorescence only in acidic media, and bioreducible degradation with high reductant level, indicating their promising application as theranostic nanoplatforms for precise imaging-guided diagnosis and chemotherapy. The DOX-loaded PGMA-DMMA microspheres with a drug-loading capacity of 18% and particle size of about 150 nm possessed unique pH/reduction dual-responsive controlled release, with a cumulative DOX release of 60.5% within 54 h at the simulated tumor microenvironment but a premature leakage of 8.0% under the simulated physiological condition. Enhanced inhibition efficacy against HepG2 cells was achieved than the free DOX.
机译:已经为具有肿瘤微环境生物环境的通用聚合物微球,PH-活化表面电荷反转,pH-触发的“脱机”荧光和药物释放通过乳化丙烯酸缩水甘油酯(GMA),聚(GMA),聚(乙烯)(乙烯)二醇)甲基醚甲基丙烯酸甲酯(PEGMA),N-罗丹明6g-乙基 - 丙烯酰胺(RH6Geam)与N,N-BIS(Acyloyl)胱胺(Bacy)作为二硫化物交联剂和官能化。最终的PGMA-DMMA微球在pH 5-6的pH 5-6中显示出优异的细胞相容性,PH-触发的表面电荷反转,仅在酸性介质中强烈荧光,并且具有高还原剂水平的生物可遗产降解​​,表明其作为治疗纳米纳薄型以精确的影像导向诊断的有前途的应用和化疗。具有18%的药物负载能力和约150nm的粒径的DOX的PGMA-DMMA微球具有独特的pH /抑制双响应控制释放,在模拟肿瘤的54小时内累积释放60.5%微环境,但过早泄漏&在模拟生理条件下8.0%。比自由DOX增强对HepG2细胞的抑制效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号